M&A Deal Summary |
|
|---|---|
| Date | 2015-09-30 |
| Target | Alfa Aesar & Co KG |
| Sector | Chemicals |
| Buyer(s) | Thermo Fisher Scientific |
| Sellers(s) | Johnson Matthey |
| Deal Type | Divestiture |
| Deal Value | 256M GBP |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1956 |
| Sector | Test/Measurement Equipment |
| Employees | 122,000 |
| Revenue | 42.9B USD (2024) |
Thermo Scientific provides analytical instruments, laboratory equipment, software, services, consumables and reagents for better workflow solutions spanning sample preparation, sample analysis, and data interpretation. Thermo Fisher Scientific was founded in 1956 and is based in Waltham, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 41 of 65 |
| Sector: Chemicals M&A | 2 of 2 |
| Type: Divestiture M&A Deals | 4 of 8 |
| Country: Germany M&A | 4 of 4 |
| Year: 2015 M&A | 1 of 1 |
| Size (of disclosed) | 20 of 29 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-07-18 |
Cole-Parmer Instrument
Vernon Hills, Illinois, United States Cole-Parmer Instrument is a global supplier of fluid handling, test & measurement, environmental, and biosciences instrumentation with expertise in peristaltic technologies, temperature control, electrochemistry, water and air testing, and chromatography. Its portfolio includes brands such as Masterflex, Environmental Express, and Traceable, serving research and production needs across life sciences, healthcare, environmental, and industrial markets. Cole-Parmer Instrument was founded in 1955 and is based in Vernon Hills, Illinois. |
Sell | $480M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-01-08 |
Affymetrix
Santa Clara, California, United States Affymetrix develops and provides technologies that enable multiplex and parallel analysis of biological systems at the cell, protein, and gene level, facilitating the rapid translation of results into biology for a better world. |
Buy | $1.3B |
| Category | Company |
|---|---|
| Founded | 1817 |
| Sector | Chemicals |
| Employees | 10,644 |
| Revenue | 11.7B GBP (2025) |
Johnson Matthey is a specialty chemicals company underpinned by science, technology, and our people. A leader in sustainable technologies, many of our products enhance the quality of life for millions worldwide. Johnson Matthey was founded in 1817 and is based in London, England.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 11 |
| Sector: Chemicals M&A | 2 of 5 |
| Type: Divestiture M&A Deals | 4 of 11 |
| Country: Germany M&A | 1 of 2 |
| Year: 2015 M&A | 1 of 1 |
| Size (of disclosed) | 5 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-03-28 |
Formox AB
Perstorp, Sweden Formox is a leading global provider of catalysts, plant designs and licences for the manufacture of formaldehyde, an important chemical intermediate. It has developed a market leading range of novel metal oxide based catalysts for the production of formaldehyde from methanol and is the leading provider of process technology for metal oxide based formaldehyde production plants with an installed base of around 130 plants worldwide. |
Buy | kr1.1B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-10-01 |
Pharmorphix
Cambridge, United Kingdom Pharmorphix Ltd. is a provider of solid form services, including polymorph studies, salt selection, co-crystallization, chiral separations and process scale up that are critical to successful drug discovery and development. |
Buy | - |
